PharmiWeb15h
Polyclonal Antibody Market Poised for Growth, Expected to Hit USD2.0 Billion by 2034 at 5.5% CAGR- TMR
The global polyclonal antibody market is poised for significant expansion in the coming decade, driven by increasing ...
Will ADMA Biologics Stock Continue Its Momentum in 2025?
ADMA continues to maintain momentum in 2025 after its stupendous performance in 2024. Strong demand for Asceniv should fuel growth.
eLife2d
Genome organization by SATB1 binding to base-unpairing regions (BURs) provides a scaffold for SATB1-regulated gene expression
Mammalian genomes are organized by multi-level folding, yet how this organization contributes to cell type-specific transcription remain unclear. We uncovered that the nuclear protein SATB1 ...
Monoclonal antibody significantly reduces nasal polyps and need for surgery in Phase 3 clinical trial
Chronic rhinosinusitis with nasal polyps presents a substantial clinical burden, affecting nasal airflow, olfactory function, ...
FMIBlog1d
Global Anti-Neurofilament L Antibody Market Poised for Significant Growth, Projected to Reach USD 790 Million by 2034
Anti-neurofilament L antibodies play a crucial role in detecting and monitoring neurodegenerative diseases, including Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), and multiple sclerosis ...
eLife3d
A delta-tubulin/epsilon-tubulin/Ted protein complex is required for centriole architecture
TEDC1 and TEDC2, functions in generating centriolar triplet microtubules, and that this is crucial for the proper formation of centriolar subdomains and the stability of centrioles throughout the cell ...
pharmaphorum5d
Artificial Intelligence for better antibody drugs: ready for prime time?
The potential of monoclonal antibodies (mAbs) as therapies is indisputable. The current mAbs market is expected to be around ~USD 150 billion. In 2021, five out of the top 10 selling drugs were ...